Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Winquist

Showing results (181-190 of 234) with videos related to

Pageof 24
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 12, 2016
Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTOG 0129Canhua Xiao, Qiang Zhang, Phuc Felix Nguyen-Tân, et al.
Oncotarget|October 27, 2017
Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancerFarhad Ghasemi, Morgan Black, Frederick Vizeacoumar, et al.
European Urology|August 17, 2021
Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter StudyPatrick Cheung, Samir Patel, Scott A North, et al.
Oncotarget|March 1, 2018
A randomized phase II study of pelareorep and docetaxel or docetaxel alone in men with metastatic castration resistant prostate cancer: CCTG study IND 209Bernhard Josef Eigl, Kim Chi, Dongsheng Tu, et al.
Case Reports in Oncological Medicine|May 9, 2013
A case report and genetic characterization of a massive acinic cell carcinoma of the parotid with delayed distant metastasesAnthony C Nichols, Michelle Chan-Seng-Yue, John Yoo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Predictive and pharmacodynamic biomarker studies in tumor and skin tissue samples of patients with recurrent or metastatic squamous cell carcinoma of the head and neck treated with erlotinibMark Agulnik, Gilda da Cunha Santos, David Hedley, et al.
JCI Insight|January 11, 2019
Mutational analysis of head and neck squamous cell carcinoma stratified by smoking statusFarhad Ghasemi, Stephenie D Prokopec, Danielle MacNeil, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 15, 2013
Management of small cell carcinoma of the bladder: Consensus guidelines from the Canadian Association of Genitourinary Medical Oncologists (CAGMO)Patricia Moretto, Lori Wood, Urban Emmenegger, et al.
Clinical Genitourinary Cancer|April 27, 2025
Optimal Timing of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Patients Considering Sarcomatoid Status: A Real-World StudyGhady Bou-Nehme Sawaya, Simon Tanguay, Lori A Wood, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 9, 2020
Prioritizing systemic therapies for genitourinary malignancies: Canadian recommendations during the COVID-19 pandemicAly-Khan A Lalani, Kim N Chi, Daniel Y C Heng, et al.
Pageof 24

Showing results (181-190 of 234) with videos related to

Sort By:
Pageof 24
International Journal of Radiation Oncology, Biology, Physics|October 12, 2016
Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTOG 0129Canhua Xiao, Qiang Zhang, Phuc Felix Nguyen-Tân, et al.
Oncotarget|October 27, 2017
Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancerFarhad Ghasemi, Morgan Black, Frederick Vizeacoumar, et al.
European Urology|August 17, 2021
Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter StudyPatrick Cheung, Samir Patel, Scott A North, et al.
Oncotarget|March 1, 2018
A randomized phase II study of pelareorep and docetaxel or docetaxel alone in men with metastatic castration resistant prostate cancer: CCTG study IND 209Bernhard Josef Eigl, Kim Chi, Dongsheng Tu, et al.
Case Reports in Oncological Medicine|May 9, 2013
A case report and genetic characterization of a massive acinic cell carcinoma of the parotid with delayed distant metastasesAnthony C Nichols, Michelle Chan-Seng-Yue, John Yoo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Predictive and pharmacodynamic biomarker studies in tumor and skin tissue samples of patients with recurrent or metastatic squamous cell carcinoma of the head and neck treated with erlotinibMark Agulnik, Gilda da Cunha Santos, David Hedley, et al.
JCI Insight|January 11, 2019
Mutational analysis of head and neck squamous cell carcinoma stratified by smoking statusFarhad Ghasemi, Stephenie D Prokopec, Danielle MacNeil, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 15, 2013
Management of small cell carcinoma of the bladder: Consensus guidelines from the Canadian Association of Genitourinary Medical Oncologists (CAGMO)Patricia Moretto, Lori Wood, Urban Emmenegger, et al.
Clinical Genitourinary Cancer|April 27, 2025
Optimal Timing of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Patients Considering Sarcomatoid Status: A Real-World StudyGhady Bou-Nehme Sawaya, Simon Tanguay, Lori A Wood, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 9, 2020
Prioritizing systemic therapies for genitourinary malignancies: Canadian recommendations during the COVID-19 pandemicAly-Khan A Lalani, Kim N Chi, Daniel Y C Heng, et al.
Pageof 24